Elevated plasma lipoprotein(a) is associated with coronary artery disease in patients with chronic stable angina pectoris

Journal of the American College of Cardiology

Volumn 31, Issue 6, 1998, Pages 1260-1266

  Schwartzman, Raúl A ^a   Cox, Ian D ^a   Poloniecki, Jan ^a   Crook, Robert ^a   Seymour, Carol A ^a   Kaski, Juan Carlos ^a,b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN A;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC DISEASE; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS;

AGED; ANGINA PECTORIS; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; HUMANS; LIPOPROTEIN(A); LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0032080742     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00096-5     Document Type: Article

References (39)

1. Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risks associated with lipoprotein(a). Nature 1989;339:301-3.
2. McLean JW, Tomlinson JE, Kuang WJ, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987;330:132-7.
3. Anglés-Cano E, Hervio L, Rouy D. Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen. Chem Phys Lipids 1994;68:369-80.
4. Utermann G. The mysteries of lipoprotein(a). Science 1989;246:904-10.
5. Ezratty A, Simon DI, Loscalzo J. Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation. Biochemistry 1993;32: 4628-33.
6. Berg K. A new serum type system in man - the lipoprotein system. Acta Pathol Microbiol Scand 1963;59:369-82.
7. Genest J Jr., Jenner JL, McNamara JR. Prevalence of lipoprotein(a) excess in coronary artery disease. Am J Cardiol 1991;67:1039-45.
8. Rhoads G, Dahlén G, Berg K, Morton N, Dannenberg A. Lipoprotein(a) as a risk factor for myocardial infarction. JAMA 1986;256:2540-4.
9. Kinlay S, Dobson AJ, Heller RF, McElduff P, Alexander H, Dickeson J. Risk of primary and recurrent acute myocardial infarction from lipoprotein(a) in men and women. J Am Coll Cardiol 1996;28:870-5.
10. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ 1990;301:1248-51.
11. Sandkamp M, Funke H, Schulte H, Koler E, Assmann G. Lipoprotein(a) as an independent risk factor for myocardial infarction at young age. Clin Chem 1990;36:20-3.
12. Cremer P, Nagel D, Labrot B, et al. Lipoprotein(a) as a predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen risk incidence and prevalence study (GRIPS). Eur J Clin Invest 1994;24:444-53.
13. Schaefer EJ, Lamon-Fava S, Jenner JL, et al. Lipoprotein(a) levels and risk of coronary heart disease in men: the Lipid Research Clinics Coronary Primary Prevention Trial. JAMA 1994;271:999-1003.
14. Assmann G, Schulte H, von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996;77:1179-84.
15. Dahlén GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM, Jr.. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986;74:758-65.
16. Labeur C, De Bacquer D, De Backer G, et al. Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography. Clin Chem 1992;38:2261-6.
17. Solymoss BC, Marcil M, Wesolowska E, Gilfix BM, Lesperance J, Campeau, L. Relation of coronary artery disease in women <60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high-density cholesterol ratio. Am J Cardiol 1993;72:1215-9.
18. Budde T, Fechtrup C, Bosenberg E, et al. Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis. Arterioscler Thromb 1994;14:1730-6.
19. Hearn J, DeMaio S, Roubin G, Hammarstrom M, Sgoutas DS. Predictive value of lipoprotein(a) and other serum lipoproteins in the angiographic diagnosis of coronary artery disease. Am J Cardiol 1990;66:1176-80.
20. Stiel GM, Reblin T, Buhrlen M, Lattermann A, Nienaber CA. Differences in lipoprotein(a) and apolipoprotein(a) levels in men and women with advanced coronary atherosclerosis. Coronary Artery Dis 1995;6:347-50.
21. Carlson LA, Hamsten A, Asplund A. Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid. J Intern Med 226:271-6, 1989.
22. Kronenberg F, Lobentanz EM, Konig P, Utermann G, Dieplinger H. Effect of sample storage on the measurement of Lp(a), apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides. J Lipid Res 1994;35:1318-28.
23. Tiran A, Tiran B, Hojas S, Kostner GM, Wilders-Truschnig MM. Immunoquantification of lipoprotein(a): comparison of nephelometry with electroimmunodiffusion. J Clin Lab Anal 1993;7:256-62.
24. Lesperance J, Hudson G, White C, Laurier J, Waters D. Comparison by quantitative angiographic assessment of coronary stenoses of one view showing the severest narrowing to two orthogonal views. Am J Cardiol 1989;64:462-5.
25. Chen L, Chester MR, Redwood S, Huang J, Leatham EW, Kaski JC. Rapid angiographic disease progression in patients with stabilised unstable angina. Circulation 1995;91:2319-24.
26. Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 1990;119:1262-7.
27. Armstrong VW, Cremer P, Eberle E, et al. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis 1986;62:249-57.
28. Seed M, Hoppichler F, Reaveley D, et al. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. New Engl J Med 1990;322: 1494-9.
29. Schwartzkopff W, Schleicher J, Pottins I, Yu SB, Han CZ, Du DY. Lipids, lipoproteins, apolipoproteins, and other risk factors in Chinese men and women with and without myocardial infarction. Atherosclerosis 1990;82: 253-9.
30. Sandholzer C, Boerwinkle E, Saha N, Tong MC, Utermann G. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J Clin Invest 1992;89:1040-6.
31. Brown MS, Goldstein JL. Plasma lipoproteins: teaching old dogmas new tricks. Nature 1987;330:113-4.
32. Maher VM, Brown BG, Marcovina SM, Hillger LA, Zhao XQ, Albers JJ. Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a). JAMA 1995;274:1771-4.
33. Jauhiainen M, Koskinen P, Ehnholm C, et al. Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991;89:59-67.
34. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 1993;270:2195-9.
35. Scanu AM. Lipoprotein(a). Link between structure and pathology. Ann Epidemiol 1992;2:407-12.
36. Scanu AM, Lawn RM, Berg K. Lipoprotein(a) and atherosclerosis. Ann Intern Med 1991;115:209-18.
37. Miles LA, Fless GM, Scanu AM, et al. Interaction of Lp(a) with plasminogen binding sites on cells. Thromb Haemost 1995;73:458-65.
38. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice. Nature 1994;370:460-2.
39. Grainger DJ, Metcalfe JC. Transforming growth factor-β: the key to understanding lipoprotein(a)? Curr Opin Lipidol 1995;6:81-5.